3-[2-Methoxy-5-(3,4,5-trimethoxy-phenoxymethyl)-phenoxy]-propane-1,2-diol

ID: ALA358037

PubChem CID: 44367323

Max Phase: Preclinical

Molecular Formula: C20H26O8

Molecular Weight: 394.42

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1ccc(COc2cc(OC)c(OC)c(OC)c2)cc1OCC(O)CO

Standard InChI:  InChI=1S/C20H26O8/c1-23-16-6-5-13(7-17(16)28-12-14(22)10-21)11-27-15-8-18(24-2)20(26-4)19(9-15)25-3/h5-9,14,21-22H,10-12H2,1-4H3

Standard InChI Key:  MGYHEJDITQIJLQ-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 28 29  0  0  0  0  0  0  0  0999 V2000
   -2.7458   -0.5917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4583   -1.1292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4333   -0.0917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8333   -0.1042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8583   -1.1500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8500   -0.7125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5458   -0.6417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1625   -0.2000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.1375   -1.2417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2500   -0.6917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9458   -0.6542    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.8167   -1.7542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0583   -1.2042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3458   -0.5792    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7625   -0.2167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7833   -1.6375    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7125    0.4458    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.0792    0.2958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6583   -1.1875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2167   -1.7292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7375   -1.2625    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7917    0.8208    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9625   -0.2500    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.6792    0.2833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6333   -0.0500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5000   -2.1667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3125    0.4625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0167   -1.7917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  1  1  0
  4  3  2  0
  5  2  1  0
  6 10  2  0
  7  4  1  0
  8  6  1  0
  9 12  2  0
 10 13  1  0
 11  7  1  0
 12 20  1  0
 13 19  1  0
 14  1  1  0
 15  8  1  0
 16  2  1  0
 17  3  1  0
 18 15  1  0
 19 11  1  0
 20 13  2  0
 21  9  1  0
 22 18  1  0
 23 24  1  0
 24 18  1  0
 25 14  1  0
 26 16  1  0
 27 17  1  0
 28 21  1  0
  7  5  2  0
  6  9  1  0
M  END

Associated Targets(Human)

K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TUBB1 Tclin Tubulin beta-1 chain (182 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 394.42Molecular Weight (Monoisotopic): 394.1628AlogP: 2.03#Rotatable Bonds: 11
Polar Surface Area: 95.84Molecular Species: NEUTRALHBA: 8HBD: 2
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 13.62CX Basic pKa: CX LogP: 1.43CX LogD: 1.43
Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.60Np Likeness Score: 0.17

References

1. Lawrence NJ, Rennison D, Woo M, McGown AT, Hadfield JA..  (2001)  Antimitotic and cell growth inhibitory properties of combretastatin A-4-like ethers.,  11  (1): [PMID:11140732] [10.1016/s0960-894x(00)00596-5]
2. Ducki S, Mackenzie G, Lawrence NJ, Snyder JP..  (2005)  Quantitative structure-activity relationship (5D-QSAR) study of combretastatin-like analogues as inhibitors of tubulin assembly.,  48  (2): [PMID:15658859] [10.1021/jm049444m]

Source